We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.32B
AUM Growth
+$174M
Cap. Flow
+$74.4M
Cap. Flow %
5.65%
Top 10 Hldgs %
23.43%
Holding
224
New
43
Increased
51
Reduced
51
Closed
37

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$31.9M
2
UTHR icon
United Therapeutics
UTHR
+$29.5M
3
VRNA
Verona Pharma
VRNA
+$20.3M
4
ARGX icon
argenx
ARGX
+$19.4M
5
DAWN
Day One Biopharmaceuticals
DAWN
+$16M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$21.9M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$16.5M
3
RGEN icon
Repligen
RGEN
+$14.8M
4
EXE
Expand Energy Corp
EXE
+$14.3M
5
BILL icon
BILL Holdings
BILL
+$13.8M

Sector Composition

Rank Sector Weight
1 Healthcare 52.51%
2 Technology 11.88%
3 Industrials 9.25%
4 Consumer Discretionary 7.08%
5 Energy 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$29.3B
$18.1M 1.38%
90,351
+37,467
+71% +$7.88M
XOM icon
27
ExxonMobil
XOM
$634B
$17.9M 1.36%
163,000
– –
WSC icon
28
WillScot Mobile Mini Holdings
WSC
$4.41B
$17.6M 1.34%
375,230
-134,542
-26% -$6.48M
PCVX icon
29
Vaxcyte
PCVX
$8.64B
$16.3M 1.24%
433,800
+310,478
+252% +$13.2M
XENE icon
30
Xenon Pharmaceuticals
XENE
$6.12B
$15.6M 1.19%
436,715
+184,413
+73% +$6.81M
CALY
31
Callaway Golf Company
CALY
$3.14B
$15.5M 1.18%
719,199
+95,311
+15% +$2.16M
CACI icon
32
CACI
CACI
$14.2B
$14.8M 1.12%
49,810
-467
-0.9% -$138K
IRDM icon
33
Iridium Communications
IRDM
$5.29B
$13.3M 1.01%
214,654
+8,606
+4% +$515K
CVX icon
34
Chevron
CVX
$366B
$13.3M 1.01%
81,350
– –
CHX
35
DELISTED
ChampionX
CHX
$13.3M 1.01%
489,080
+90,431
+23% +$2.7M
BHVN icon
36
Biohaven
BHVN
$2.21B
$12.3M 0.93%
+900,270
New +$14.3M
DICE
37
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$11.9M 0.91%
+416,151
New +$12.3M
CELH icon
38
Celsius Holdings
CELH
$7.03B
$11.6M 0.89%
375,999
+3,363
+0.9% +$106K
WING icon
39
Wingstop
WING
$3.18B
$10.4M 0.79%
56,599
-6,711
-11% -$1.1M
SYM icon
40
Symbotic
SYM
$5.22B
$9.26M 0.7%
405,569
-80,787
-17% -$1.35M
ARCB icon
41
ArcBest
ARCB
$3.08B
$8.79M 0.67%
+95,107
New +$8.55M
KKR.PRC
42
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
– –
0
– –
VKTX icon
43
Viking Therapeutics
VKTX
$4B
$8.44M 0.64%
+507,070
New +$5.24M
MSFT icon
44
Microsoft
MSFT
$3.71T
$8.39M 0.64%
29,100
-12,696
-30% -$3.24M
TMHC
45
DELISTED
Taylor Morrison
TMHC
$8.38M 0.64%
219,073
+89,132
+69% +$3.13M
AVGO icon
46
Broadcom
AVGO
$2.04T
$8.12M 0.62%
126,510
-18,110
-13% -$1.09M
ARES icon
47
Ares Management
ARES
$30.9B
$8.02M 0.61%
96,105
– –
ROIV icon
48
Roivant Sciences
ROIV
$26.2B
$7.91M 0.6%
+1,072,383
New +$8.83M
BJ icon
49
BJs Wholesale Club
BJ
$12.3B
$7.84M 0.6%
103,012
-118,291
-53% -$8.59M
CDNS icon
50
Cadence Design Systems
CDNS
$93.4B
$6.97M 0.53%
33,160
-6,323
-16% -$1.2M
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Nicholas Investment Partners held 224 positions worth $1.32B, up 15% from $1.14B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nicholas Investment Partners deployed $74.4M of net new capital in Q1 2023, opening 43 new positions and adding to 51 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 117,047 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Expand Energy Corp, an estimated $14.3M trimmed.

  • Nicholas Investment Partners's largest Q1 2023 buy was Madrigal Pharmaceuticals: 117,047 shares worth $28.4M.
  • Nicholas Investment Partners added most to argenx in Q1 2023, an estimated $19.4M increase.
  • Nicholas Investment Partners's biggest Q1 2023 reduction was Expand Energy Corp, cutting an estimated $14.3M.
  • Nicholas Investment Partners fully exited Intra-Cellular Therapies Inc. in Q1 2023, selling an estimated $21.9M.
  • Nicholas Investment Partners's ten largest holdings make up 23% of its $1.32B portfolio in Q1 2023.
  • Nicholas Investment Partners opened 43 new positions and closed 37 in Q1 2023.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.32B.

Based on Nicholas Investment Partners's 13F filing for Q1 2023, filed 12 May 2023.